Literature DB >> 1645966

Clonidine-displacing substance (CDS) and its putative imidazoline receptor. New leads for further divergence of alpha 2-adrenergic receptor activity.

D Atlas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1645966     DOI： 10.1016/0006-2952(91)90152-u

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  18 in total

Review 1.  Biological significance of agmatine, an endogenous ligand at imidazoline binding sites.

Authors:  W Raasch; U Schäfer; J Chun; P Dominiak
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells.

Authors:  J C Jonas; T D Plant; J C Henquin
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

3.  Imidazoleacetic acid-ribotide in vestibulo-sympathetic pathway neurons.

Authors:  Gay R Holstein; Victor L Friedrich; Giorgio P Martinelli
Journal:  Exp Brain Res       Date:  2016-07-13       Impact factor: 1.972

4.  Imidazoleacetic acid-ribotide induces depression of synaptic responses in hippocampus through activation of imidazoline receptors.

Authors:  O Bozdagi; X B Wang; G P Martinelli; G Prell; V L Friedrich; G W Huntley; G R Holstein
Journal:  J Neurophysiol       Date:  2011-01-12       Impact factor: 2.714

5.  Attenuated renal response to moxonidine and rilmenidine in one kidney-one clip hypertensive rats.

Authors:  P Li; S B Penner; D D Smyth
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

6.  Antagonism of levcromakalim by imidazoline- and guanidine-derivatives in rat portal vein: involvement of the delayed rectifier.

Authors:  T Ibbotson; G Edwards; A H Weston
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

7.  Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites.

Authors:  C A Brown; A C Loweth; S A Smith; N G Morgan
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

8.  Agmatine recognizes alpha 2-adrenoceptor binding sites but neither activates nor inhibits alpha 2-adrenoceptors.

Authors:  D Pinthong; I K Wright; C Hanmer; P Millns; R Mason; D A Kendall; V G Wilson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

9.  Evidence for the presence of a non-catecholamine, clonidine-displacing substance in crude, methanolic extracts of bovine brain and lung.

Authors:  G Singh; J F Hussain; A MacKinnon; C M Brown; D A Kendall; V G Wilson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

10.  Imidazoline binding sites in human placenta: evidence for heterogeneity and a search for physiological function.

Authors:  S Diamant; T Eldar-Geva; D Atlas
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.